Outside the Box: How Palantir's early experience in Japan helped set up its successful IPOMarket Watch • 12/08/20
Palantir surges 17% after it wins FDA contract worth $44 million, report says (PLTR)Business Insider • 12/07/20
Palantir's Stock Surge Is Hype, Morgan Stanley Warns In Downgrade, Shares Plummet 12%Forbes • 12/02/20